Framework on how to safely resume essential cardiovascular diagnostic and treatment care during the COVID-19 pandemic, from the AHA and 14 North American cardiovascular societies

May 04, 2020

DALLAS, May 4, 2020 -- The American Heart Association, together with 14 cardiovascular societies in North America, today issued joint guidance, "Safe Reintroduction of Cardiovascular Services during the COVID-19 Pandemic: Guidance from North American Society Leadership," to outline a systematic, phased approach to safely reintroducing cardiovascular procedures for diagnosis and treatment during the COVID-19 pandemic.

"We acted quickly to protect patients and health care professionals when COVID-19 arrived in the United States, and for many patients, essential diagnostic, interventional or surgical cardiovascular procedures performed at hospitals were postponed. As many states have begun to re-open or introduce progressive re-openings since the national COVID-19 lockdown, this guidance provides a critical framework for prioritizing and resuming cardiovascular care as safely and as appropriately as possible," stated Robert Harrington, M.D. FAHA, president of the American Heart Association, Arthur L. Bloomfield Professor of Medicine and chair of the department of medicine at Stanford University. "We must continue to strike the delicate balance of ensuring optimal and timely cardiovascular care that can reduce morbidity and mortality, weighed against the risk of COVID-19 exposure. A tailored and collaborative approach that adapts based on the number of COVID cases and the mortality rate within each community, in tandem with local health and government leaders, is ideal. The safety of our patients and their families from both cardiovascular disease and COVID-19 is our priority."

As significant delays in diagnosis and/or treatment can lead to serious consequences for cardiovascular patients, it is appropriate that these patients are prioritized as health care systems return to normal capacity. The challenge this presents for health care delivery systems and providers is how to reintroduce cardiovascular services while ensuring the safety of patients, providers and their families.

The framework balances the risk of COVID-19 exposure with the need for prompt diagnosis and treatment of cardiovascular disease. It highlights the importance of adequate supplies of personal protective equipment and COVID-19 testing for patients and staff, while at the same time protecting the pre-pandemic gains made in reducing morbidity and mortality from cardiovascular disease.
The guidance is from the American Heart Association, the American College of Cardiology, the American Society of Echocardiography, the American Society of Nuclear Cardiology, the Canadian Association of Interventional Cardiology, the Canadian Cardiovascular Society, Canadian Heart Failure Society Heart Rhythm Society, Canadian Society of Cardiac Surgeons, the Heart Valve Society, the Society for Cardiovascular Angiography and Interventions, the Society for Cardiovascular Magnetic Resonance, the Society of Cardiovascular Computed Tomography, the Society of Nuclear Medicine and Molecular Imaging and the Society of Thoracic Surgeons, and is jointly published in the Canadian Journal of Cardiology, the Journal of the American College of Cardiology and The Annals of Thoracic Surgery.

Co-authors of the statement are David A. Wood, M.D.; Ehtisham Mahmud, M.D.; Vinod H. Thourani, M.D.; Janarthanan Sathananthan, M.B.Ch.B., M.P..H; Alice Virani, M.A., M.S., M.P.H., Ph.D.; Athena Poppas, M.D.; Robert A. Harrington, M.D.; Joseph A. Dearani, M.D.; Madhav Swaminathan, M.D.; Andrea M. Russo, M.D.; Ron Blankstein, M.D.; Sharmila Dorbala, M.D.; James Carr, M.D.; Sean Virani, M.D., M.Sc., M.P.H.; Kenneth Gin, M.D.; Alan Packard, Ph.D.; Vasken Dilsizian, M.D.; Jean-François Légaré, M.D.; Jonathon Leipsic, M.D.; John G. Webb, M.D.; and Andrew D. Krahn, M.D. Disclosures are detailed in the manuscript.

The American Heart Association is a relentless force for a world of longer, healthier lives. We are dedicated to ensuring equitable health in all communities. Through collaboration with numerous organizations, and powered by millions of volunteers, we fund innovative research, advocate for the public's health and share lifesaving resources. The Dallas-based organization has been a leading source of health information for nearly a century. Connect with us on, Facebook, Twitter or by calling 1-800-AHA-USA1.

American Heart Association

Related Cardiovascular Disease Articles from Brightsurf:

Changes by income level in cardiovascular disease in US
Researchers examined changes in how common cardiovascular disease was in the highest-income earners compared with the rest of the population in the United States between 1999 and 2016.

Fighting cardiovascular disease with acne drug
Researchers from the European Molecular Biology Laboratory (EMBL) in Heidelberg and Stanford University have found the cause of dilated cardiomyopathy - a leading cause of heart failure - and identified a potential treatment for it: a drug already used to treat acne.

A talk with your GP may prevent cardiovascular disease
Having a general practitioner (GP) who is trained in motivational interviewing may reduce your risk of getting cardiovascular disease.

Dilemma of COVID-19, aging and cardiovascular disease
Whether individuals should continue to take angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in the context of coronavirus disease 2019 (COVID-19) is discussed in this article.

Air pollution linked to dementia and cardiovascular disease
People continuously exposed to air pollution are at increased risk of dementia, especially if they also suffer from cardiovascular diseases, according to a study at Karolinska Institutet in Sweden published in the journal JAMA Neurology.

New insights into the effect of aging on cardiovascular disease
Aging adults are more likely to have - and die from - cardiovascular disease than their younger counterparts.

Premature death from cardiovascular disease
National data were used to examine changes from 2000 to 2015 in premature death (ages 25 to 64) from cardiovascular disease in the United States.

Ultrasound: The potential power for cardiovascular disease therapy
In the current issue of Cardiovascular Innovations and Applications volume 4, issue 2, pp.

Despite the ACA, millions of Americans with cardiovascular disease still can't get care
Cardiovascular disease (CVD) is the leading cause of death for Americans, yet millions with CVD or cardiovascular risk factors (CVRF) still can't access the care they need, even years after the implementation of the Affordable Care Act (ACA).

Excess weight and body fat cause cardiovascular disease
In the first Mendelian randomization study to look at this, researchers have found evidence that excess weight and body fat cause a range of heart and blood vessel diseases (rather than just being associated with it).

Read More: Cardiovascular Disease News and Cardiovascular Disease Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to